EverHint – EMA10 × Price × MACD Signals for Jan 27, 2026 – Technology Leads with 3 Setups
What This Signal Is (Quick)
This is an experimental strategy that combines two bullish signals occurring on the same day:
-
Price crosses above EMA10 from below
- Yesterday:
price_prev <= ema10_prev - Today:
price > ema10 - Indicates price breaking above short-term trend
- Yesterday:
-
MACD Line crosses above Signal Line from below
- Yesterday:
macd_line_prev <= macd_signal_prev - Today:
macd_line > macd_signal - Confirms bullish momentum shift
- Yesterday:
Double Confirmation: Both crossovers must happen simultaneously on the signal date, providing higher-quality setups with stronger conviction.
Key Characteristics:
- Buy signals only - This strategy generates only bullish signals (no sell signals)
- Fewer but higher quality - Dual confirmation means 5-20 signals per day vs. 20-40 for single-indicator strategies
- Fast response - EMA10 catches early momentum shifts
- Momentum context - MACD adds underlying momentum confirmation
- Swing trading focus - Ideal for 1-4 week holding periods
Key Criteria:
-
Buy: Price > EMA10 AND MACD line crosses above signal line
-
Sell: Price < EMA10 AND MACD line crosses below signal line
-
Minimum ADV: $40M (liquidity filter)
-
Earnings buffer: 7 days pre/post earnings
-
Fresh signal: All conditions met on today's close
Holding Period: 1-3 weeks
Risk Level: Medium-High
How We Ranked Today
Ranked by RSI (lower RSI = more oversold for buy signals)
📊 EMA10 × Price × MACD Signals (7 Total)
Ranked by rsi14:
| Rank | Ticker | Company | Sector | Last ($) | RSI14 | Insider Net | Days → Earnings | Est EPS | Mkt Cap ($B) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MRVL | Marvell Technology, Inc. | Technology | 82.93 | 35.1 | — | 36 | $6.24 | 71.5 |
| 2 | INSM | Insmed Incorporated | Healthcare | 162.64 | 38.7 | $-4.9M | 23 | $8.88 | 34.7 |
| 3 | BZ | KANZHUN LIMITED - Amer... | Communication Services | 19.28 | 38.9 | — | 42 | $11.23 | 3.9 |
| 4 | GBDC | Golub Capital BDC, Inc. | Financial Services | 13.71 | 49.5 | — | 7 | $1.26 | 3.7 |
| 5 | FN | Fabrinet | Technology | 498.59 | 55.1 | $-4.7M | 6 | $18.87 | 17.9 |
| 6 | RYTM | Rhythm Pharmaceuticals... | Healthcare | 105.53 | 56.3 | — | 29 | $9.78 | 7.0 |
| 7 | TSEM | Tower Semiconductor Ltd. | Technology | 132.62 | 63.7 | — | 13 | $4.46 | 14.8 |
Field Notes
Sector concentration: Technology (3), Healthcare (2), Communication Services (1)
Insider selling: INSM (Insmed Incorporated, $-4.9M), FN (Fabrinet, $-4.7M)
Near-term earnings: FN (Fabrinet), GBDC (Golub Capital BDC, Inc.) report within 7 days. Higher volatility risk.
Data coverage: 28.6% insider, 0.0% congressional, 100.0% earnings, 100.0% analyst, 14.3% news
Recent Headlines
TSEM (Tower Semiconductor Ltd.)
- Tower Semiconductor Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Conference Call (source)
Market Context
Current market conditions show a mixed performance across major indices, with the S&P 500 edging up 0.18% and the Nasdaq advancing 0.35%, while the Dow Jones dipped 0.20%. This divergence points to a cautious risk appetite, favoring growth-oriented areas amid selective buying. For an EMA10 price MACD strategy, which relies on short-term momentum crossovers, this environment supports potential bullish signals in leading sectors, but the lack of uniform trend direction increases the risk of false breakouts, particularly with only 7 total signals generated.
The VIX at 16.35, up 2.06%, indicates moderate volatility that's creeping higher, likely amplifying intraday swings and testing the sensitivity of fast-reacting indicators like the 10-period EMA and MACD histogram. In such conditions, signals may capture quick reversals effectively but could suffer from noise, warranting confirmation from volume or higher timeframes to filter whipsaws. Overall, the setup favors nimble trading over aggressive positioning.
Technology's dominance as the top sector aligns with Nasdaq strength, suggesting sector rotation toward high-beta names amid subdued broader market gains. This bolsters the reliability of EMA10 MACD signals in tech, where momentum can persist, though rising VIX tempers conviction and highlights the need for disciplined risk management to navigate potential pullbacks in laggard areas like those reflected in the Dow's decline.
Sharing Call-to-Action
🎯 If this clarity helped your research, liking, sharing, or subscribing helps keep this project strong.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/